Furadonin® [Nitrofurantoin]

Brand Olainfarm

In stock 591 Items

Available since: 2019-09-19

Dosage form

pills

Brand & Manufacturer

Package Size

100 mg, 20 pcs

$24.81

Quantity

All payments are SSL encrypted
Full Refund if you haven't received your order
International shipping to the USA, UK and Europe

Clinical Pharmacology

Furadonin - an antimicrobial drug, is a derivative of nitrofuran. It has a bactericidal and bacteriostatic effect in urinary tract infections, has a wide spectrum of action. Active against most strains of Escherichia coli, Staphylococcus spp., Streptococcus spp., Salmonella typhi, Salmonella paratyphi A, Salmonella paratyphi B, Shigella sonnei, Proteus, Enterobacter spp.

Indications

Infectious and inflammatory diseases of the urinary tract, caused by microorganisms sensitive to the drug:
pyelitis; pyelonephritis; cystitis; urethritis;
Prevention of infections during urological operations or examination (cystoscopy, catheterization, etc.).

Composition

active substance: 100 mg nitrofurantoin

Nitrofurantoin is marketed under different brands and generic names, and comes in different dosage forms:

Brand name	Manufacturer	Country	Dosage form
Furadonin	Olainfarm	Latvia	pills
Furadonin	Irbit HFZ	Russia	pills
Furadonin	BPMP	Belarus	pills

No customer reviews for the moment.

Write your review

Dosage and Administration

Inside, drinking plenty of water, adults - 0.1-0.15 g, 3-4 times a day; children - at the rate of 5-8 mg / kg / day, the daily dose is divided into 4 doses. Higher doses for adults: single - 0.3 g, daily - 0.6 g.

For acute urinary tract infections, the duration of treatment is 7-10 days.

Preventive, anti-relapse treatment continues, depending on the nature of the disease, from 3 to 12 months. The daily dose in this case is 1-2 mg / kg.

Adverse reactions

Nausea, vomiting, allergic reactions (lupus-like syndrome, arthralgia, myalgia, anaphylaxis, chills, eosinophilia, rash), dizziness, headache, asthenia, nystagmus, drowsiness, interstitial changes in the lungs, broncho-obstructive syndrome, nonstagmus, drowsiness, interstitial changes in the lungs, broncho-obstructive syndrome, nonstagmus, drowsiness, interstitial changes in the lungs, broncho-obstructive syndrome, nonstagmus, drowsiness, interstitial changes in the lungs, broncho-obstructive syndrome, dysfunction, dysphagia, dysfunction , hepatitis, cholestatic syndrome, peripheral neuropathy, pancreatitis, pseudomembranous enterocolitis, rarely - abdominal pain, diarrhea.

Contraindications

Hypersensitivity, chronic renal failure;
heart failure II – III century;
cirrhosis of the liver;
chronic hepatitis;
deficiency of glucose-6-phosphate dehydrogenase;
acute porphyria;
pregnancy and lactation;
children's age up to 3 years.

Drug interactions

The simultaneous use of nalidixic acid and antacids containing magnesium trisilikat reduces the antibacterial effect.

Incompatibility with fluoroquinolones.

Drugs that block tubular secretion, reduce the antibacterial effect (by reducing the concentration of nitrofurantoin in the urine) and increase the toxicity (increased concentration in the blood) of the drug.

Pregnancy and Lactation

The use of the drug during pregnancy and during breastfeeding is contraindicated.

Special instructions

Impact on the ability to drive vehicles and other mechanisms that require high concentration of attention

During the period of treatment, care must be taken when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and psychomotor speed (with the appearance of dizziness and drowsiness).